Leigh Purvis is a Senior Strategic Policy Advisor with AARP's Public Policy Institute. Her work focuses on a variety of prescription drug and mental health-related issues, with a particular emphasis on prescription drug pricing, biologic drugs, and Medicare Part D. She also co-authors the Public Policy Institute's Rx Price Watch reports, which track price trends for prescription drugs widely used by older Americans.
Prior to coming to AARP, she worked for the American Psychological Association. She received her M.P.A with a concentration in health administration and policy from George Mason University and her B.S. in Psychology from Mary Washington College. Leigh also holds a certificate in gerontology from the University of Washington.
Areas of expertise
Prescription drug pricing, biologic drugs, Medicare Part D
Selected publications
Medicare Part D Open Enrollment: Tough Choices for 2011 as Plans Change, Costs Shift
Biologics in Perspective: The Case for Generic Biologic Drugs





